What is the pathophysiology of peptic ulcers in a typical adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Peptic Ulcer Disease

Core Mechanism

Peptic ulceration fundamentally occurs when acid-peptic damage to the gastroduodenal mucosa results in mucosal erosion that exposes underlying tissues to the digestive action of gastroduodenal secretions, representing an imbalance between aggressive factors (acid and pepsin) and mucosal defense mechanisms. 1

Primary Pathogenic Factors

Aggressive Factors

  • Acid and pepsin secretion remains the critical permissive factor—the principle "no acid, no ulcer" holds true, as peptic ulceration cannot occur without gastric acid 2, 3
  • Duodenal ulcer patients demonstrate increased acid-pepsin secretion in response to various stimuli, though this abnormality is not present in all patients and tends to cluster in subgroups 2
  • Pepsin 1 (the ulcer-associated pepsin) has particularly potent proteolytic activity against the mucosal barrier 4

Defective Mucosal Defense

  • Impaired defense mechanisms are relatively more important than aggressive factors in the pathogenesis, particularly for acute ulcers and gastric corpus ulcers 2, 3
  • Key defense defects include:
    • Reduced prostaglandin synthesis and release 3
    • Impaired mucus and bicarbonate secretion 3
    • Compromised luminal hydrophobic layer 3
    • Possible defects in gastric mucosal blood flow 2

Major Etiologic Agents

Helicobacter pylori Infection

  • H. pylori is the main causative agent in gastroduodenal ulcer disease, representing the predominant mechanism worldwide and fundamentally changing the epidemiology of peptic ulcer disease 5, 6
  • The infection is found in approximately 53% of patients with bleeding ulcers, surpassing NSAIDs as the most commonly identified risk factor 5
  • H. pylori increases the risk of upper GI complications in NSAID users by 2- to 4-fold 5

NSAID and Aspirin Use

  • NSAIDs are the second most important pharmacologic cause, affecting acid secretion in the gastric mucosa 5, 6
  • The gastric mucosa is at least as vulnerable as the duodenal mucosa to NSAID injury, and probably more so—most drug-induced ulcers occur in the stomach 2
  • When aspirin is combined with NSAIDs, the relative risk of GI bleeding increases to more than 10 times that seen with either agent alone 5
  • The combination of H. pylori infection and NSAID use synergistically increases the risk of bleeding ulcers more than sixfold 7

Additional Contributing Factors

  • Corticosteroids affect acid secretion and increase risk, particularly when combined with NSAIDs 5, 6
  • Smoking and high-salt-content diet alter gastric mucosal integrity 5, 6
  • Alcohol abuse has contributed to changing disease epidemiology 1

Pathophysiologic Distinctions by Ulcer Type

Acute Ulcers and Erosions

  • Present clinically with gastrointestinal bleeding or perforation rather than pain 2
  • Local ischemia is the earliest recognizable gross lesion 2
  • Factors concerning mucosal defense are relatively more important than aggressive factors 2
  • If they heal, there is no predictable recurrence pattern 2

Chronic Duodenal Ulcers

  • Characterized by recurrent true peptic ulcers (penetrating the muscularis mucosae) that usually present with abdominal pain 2
  • Approximately 50% of patients experience recurrence within one year if anti-ulcer medication is stopped 2
  • Recent evidence indicates genetic and familial factors play a role 2
  • Patients demonstrate postprandial hypersecretion of acid and hypergastrinemia with accelerated gastric emptying in "idiopathic" cases 8

Chronic Gastric Ulcers

  • In gastric ulcers of the corpus, defective defense mechanisms appear more important than aggressive factors 2
  • Key mechanisms include:
    • Duodenogastric reflux 2
    • Atrophic gastritis 2
  • Nevertheless, antisecretory medications still accelerate healing, indicating acid remains permissive 2

Critical Clinical Implications

  • Heterogeneity is the most important consideration in peptic ulcer pathophysiology—different causes often coexist in a given patient 2, 8
  • As many as 20% of ulcer patients may be H. pylori-negative upon presentation, with other causes including surreptitious NSAID use, hypersecretory states, or Crohn's disease 8
  • The principle "normal healing, no ulcer" is as valid as "no acid, no ulcer," emphasizing that correction of mucosal defense deficiencies is critical 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The pathophysiology of peptic ulcer disease.

Digestive diseases and sciences, 1985

Guideline

Peptic Ulcer Disease Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gastric Perforation Causes and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management approach for a bleeding gastric ulcer that is negative for H. pylori on biopsy?
What is the appropriate diagnostic and treatment approach for a patient presenting with recurrent abdominal pain and a history of peptic ulcers suggestive of Helicobacter pylori (H. pylori) infection?
Can Helicobacter pylori (H. pylori) infection cause colon ulcers?
Can Helicobacter pylori (H. pylori) infection cause peptic ulcers in adults?
What are the different etiologies of peptic ulcers?
What is the approach to anticoagulation in patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) and Pulmonary Embolism (PE), considering factors such as Impaired renal function?
What treatment is recommended for a patient with a history of COVID-19 (Coronavirus Disease 2019) 3 weeks prior, presenting with persistent symptoms of sore throat, scratchy throat, congestion, and coughing up thin sputum?
What is the recommended dosing for Luvox (fluvoxamine) in a patient with obsessive-compulsive disorder (OCD)?
What is the workup and treatment for a patient with low sex hormone binding globulin (SHBG) and normal testosterone levels?
What is the recommended treatment for a patient with pneumonia who has an allergy to amoxicillin (a penicillin antibiotic)?
What is the first-line LABA (Long-Acting Beta Agonist)/LAMA (Long-Acting Muscarinic Antagonist) combination for a patient with upper lobe atelectasis and a history of obstructive lung disease, such as COPD (Chronic Obstructive Pulmonary Disease)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.